Clemizole - Eiger BioPharmaceuticalsAlternative Names: Clemizole hydrochloride
Latest Information Update: 16 Jul 2016
Price : $50
At a glance
- Originator Eiger BioPharmaceuticals
- Developer Eiger BioPharmaceuticals, Inc.
- Class Antiallergics; Antihistamines; Benzimidazoles; Small molecules
- Mechanism of Action Hepatitis C virus NS4 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatitis-C in New Zealand (PO, Capsule)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatitis-C in Australia (PO, Capsule)
- 22 Mar 2016 Celladon has merged with Eiger BioPharmaceuticals and the combined company is now called Eiger BioPharmaceuticals, Inc.